A Digital Microfluidic Device Integrated with Electrochemical Impedance Spectroscopy for Cell-Based Immunoassay

Yuqian Zhang1,2, Yuguang Liu1,2,3

  • 1Department of Surgery, Division of Surgical Research, Mayo Clinic, Rochester, MN 55905, USA.

Biosensors
|May 28, 2022
PubMed

Insights

This study presents a new digital microfluidic device with an electrochemical biosensor to easily and sensitively measure peripheral blood mononuclear cells (PBMCs). This tool can track immune responses for disease and therapy monitoring.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Analytical Chemistry

Background:

  • Dynamic immune responses are key indicators of disease status and treatment efficacy.
  • Peripheral blood mononuclear cells (PBMCs) are crucial for assessing immune function.
  • A simple, sensitive, and frequent method for immune system assessment is needed.

Purpose of the Study:

  • To develop an integrated system for quantifying PBMC abundance.
  • To create a user-friendly tool for assessing immune function.
  • To enable timely profiling of immune-mediated therapeutic responses.

Main Methods:

  • Integration of an electrochemical impedance spectroscopy (EIS)-based biosensor with a digital microfluidic (DMF) device.
  • Utilizing DMF's droplet manipulation for a dynamic cell capture assay.
  • Quantification of PBMC abundance using the developed system.

Main Results:

  • The integrated system achieved a 2.4-fold signal enhancement through dynamic cell capture.
  • Demonstrated sensitivity down to 10^4 PBMCs/mL.
  • The system is easy-to-operate and sensitive for PBMC quantification.

Conclusions:

  • The developed integrated system offers a sensitive and user-friendly approach for PBMC quantification.
  • It holds significant potential for monitoring immune responses to diseases and therapies.
  • Future evolution towards a point-of-care diagnostic device for near-patient testing is feasible.